• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Is immunotherapy for habitual aborters an immunologically hazardous procedure for infants?

作者信息

Takakuwa K, Goto S, Hasegawa I, Ueda H, Maruhashi T, Kajino T, Yoshizawa H, Kanazawa K, Takeuchi S

机构信息

Department of Obstetrics and Gynecology, Niigata University School of Medicine, Japan.

出版信息

Am J Reprod Immunol. 1989 Feb;19(2):53-6. doi: 10.1111/j.1600-0897.1989.tb00548.x.

DOI:10.1111/j.1600-0897.1989.tb00548.x
PMID:2765134
Abstract

Physical development and tests of immunologic function are reported from the first year of life for 13 infants born to mothers who were habitual aborters and who had undergone subcutaneous vaccination with their husband's lymphocytes. The mean weight of the infants at birth was 2,975 +/- 540 g, including one infant who was small for dates. Physical development parameters for the first year were all within normal range. Immunologic studies were performed at ages 0, 1, 3, 6, 9, and 12 months. The studies included the following: (1) serum levels of immunoglobulins and complement components; (2) the number of peripheral blood lymphocytes (PBL) and their subpopulations; and (3) proliferative responses by PBL against unrelated lymphocytes and some mitogens (pokeweed, phytohemagglutinin, and concanavalin A). All were normal when compared with studies of infants of nonimmunized mothers. These observations suggested that subcutaneous vaccination of women with their husband's lymphocytes did not result in any adverse effects on their infants' physical or immunologic development.

摘要

相似文献

1
Is immunotherapy for habitual aborters an immunologically hazardous procedure for infants?
Am J Reprod Immunol. 1989 Feb;19(2):53-6. doi: 10.1111/j.1600-0897.1989.tb00548.x.
2
[The evidence of safety of immunotherapy for unexplained habitual aborters].[免疫疗法对不明原因习惯性流产者的安全性证据]
Nihon Sanka Fujinka Gakkai Zasshi. 1992 Apr;44(4):405-11.
3
Result of immunotherapy on patients with unexplained recurrent abortion: a beneficial treatment for patients with negative blocking antibodies.
Am J Reprod Immunol. 1990 Jun;23(2):37-41. doi: 10.1111/j.1600-0897.1990.tb00667.x.
4
Influence of immunotherapy on the cellular immunity of unexplained recurrent aborters.免疫疗法对不明原因复发性流产患者细胞免疫的影响。
J Reprod Immunol. 1991 Jul;20(2):153-63. doi: 10.1016/0165-0378(91)90031-k.
5
Immunotherapy with husband's leukocytes to primary habitual aborters and autoantibodies in their sera.用丈夫的白细胞对原发性习惯性流产者及其血清中的自身抗体进行免疫治疗。
J Obstet Gynaecol Res. 1997 Feb;23(1):51-7. doi: 10.1111/j.1447-0756.1997.tb00805.x.
6
Is an additional vaccination necessary for a successful second pregnancy in unexplained recurrent aborters who were successfully immunized with their husband's lymphocytes before the first pregnancy?
Am J Reprod Immunol. 1993 Jan;29(1):39-44. doi: 10.1111/j.1600-0897.1993.tb00835.x.
7
[Analysis on the CTL-p frequency before and after immunotherapy for patients with unexplained habitual abortion].[不明原因习惯性流产患者免疫治疗前后细胞毒性T淋巴细胞前体频率分析]
Nihon Sanka Fujinka Gakkai Zasshi. 1993 Jun;45(6):527-32.
8
Production of blocking antibodies by vaccination with husband's lymphocytes in unexplained recurrent aborters: the role in successful pregnancy.在不明原因复发性流产患者中通过接种丈夫的淋巴细胞产生封闭抗体:其在成功妊娠中的作用。
Am J Reprod Immunol Microbiol. 1986 Jan;10(1):1-9. doi: 10.1111/j.1600-0897.1986.tb00001.x.
9
Prevalence of MLR blocking antibodies before and after immunotherapy.免疫治疗前后MLR阻断抗体的患病率。
J Hematother Stem Cell Res. 2000 Apr;9(2):257-62. doi: 10.1089/152581600319478.
10
Results of immunotherapy for patients with unexplained secondary recurrent abortions.
Clin Immunol. 2003 Mar;106(3):175-80. doi: 10.1016/s1521-6616(02)00044-x.